Comparison Astria Therapeutics (ATXS) with Competitors
Astria Therapeutics (ATXS) industry is Biotechnology.
Free Cash Flow Yield
ATXS-16.95%
Industry-1.75%
Upside-15.20%
P/E
ATXS-5.72
Industry-20.52
Upside+1479.33%
Astria Therapeutics (ATXS) industry is Biotechnology.